SPONSOR

Yale University

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 4, EARLY_Phase 1, Phase 3

Conditions studied: HIV Depression Cannabis Use Disorder Stress Pain Firearm Injury Breast Cancer Metastatic Chronic Pain Opioid Use Disorder Mental Health Issue

Yale University is a clinical research sponsor with 45 registered studies on ClinicalTrials.gov, of which 45 are actively recruiting participants. Research covers conditions including HIV, Depression, Cannabis Use Disorder, Stress.

The trial portfolio spans Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Yale University

How many clinical trials has Yale University sponsored?

ClinicalMetric currently tracks 45 clinical trials sponsored by Yale University, of which 45 are actively recruiting participants. These trials cover conditions including HIV, Depression, Cannabis Use Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Yale University research focus on?

Yale University clinical trials span HIV, Depression, Cannabis Use Disorder, Stress, Pain, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Yale University clinical trial?

To participate in a Yale University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yale University trials with current recruitment status updated daily.

Yale University

Frequently Asked Questions — Yale University

Clinical Trials by Yale University

Stress and Pain in People Living With HIV

TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Combined THC and CBD for OUD and Chronic Pain

Mental Health Stigma in Rural Uganda

Genomic Predictors of Recurrent Pregnancy Loss

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

Blood Pressure Variability and Ischemic Stroke Outcome

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

Investigation of Lymph Node Biology in Kidney Cancer

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Acute Effects of THC in Older Adult

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Mechanistic Studies of Psilocybin in Headache Disorders

Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)

Addictive Threshold of Nicotine

A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

Supporting Parents in Affirming Their Children's Experiences of Stigma

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Peru Decentralized HIV Care

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Evaluation of a Mobile App Program for Coping With Cancer

Speech Motor Learning and Retention (Master Protocol)

Implementing Suicide Prevention Into Primary Care in Nepal

fMRI and Opioid Abstinence

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

Opioid Use Disorder and Pain

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

Time to BBVNA Relief

Music for Pain and Dementia

Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness

Long Term Evaluation of Scapular-inserted Contraceptive Implants

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

The Recovery in Stroke Using PAP Study

SGM Evidenced-Based Mental Healthcare Implementation

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Nourishing Hope: The Impact of Nutrition in Cancer Treatment and Recovery in Maine